Antiviral Drugs Market Size, Share & Trends Report

Antiviral Drugs Market Size, Share & Trends Analysis Report By Type (Branded, Generics), By Drug Class, By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-1-68038-389-8
Number of Report Pages: 180
Format: PDF, Horizon Databook

Historical Range: 2018 - 2021
Forecast Period: 2023 - 2030
Industry: Healthcare

Market Segmentation

Antiviral Drugs Type Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Branded
- Generics
Antiviral Drug Class Scope Outlook (Revenue, USD Million, 2018 - 2030)
- DNA Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Neuraminidase Inhibitors
- Others
Antiviral Drugs Distribution Channel Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Antiviral Drugs Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
- HIV
- Hepatitis
- Herpes
- Influenza
- Others
Antiviral Drugs Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
    - Branded
    - Generics
  - North America Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - North America Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - North America Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - U.S.
    - U.S. Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - U.S. Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - U.S. Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - U.S. Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Canada
    - Canada Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Canada Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Canada Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Canada Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
- Europe
  - Europe Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
    - Branded
    - Generics
  - Europe Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - Europe Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - Europe Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - UK
    - UK Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - UK Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - UK Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - UK Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Germany
    - Germany Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Germany Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Neuraminidase Inhibitors
      - Protease Inhibitors
      - Others
    - Germany Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Germany Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - France
    - France Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - France Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - France Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - France Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Italy
    - Italy Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Italy Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Italy Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Italy Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Spain
    - Spain Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Spain Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Spain Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Spain Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Denmark
    - Denmark Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Denmark Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Denmark Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Denmark Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Sweden
    - Sweden Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Sweden Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Sweden Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Sweden Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Norway
    - Norway Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Norway Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Norway Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Norway Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
- Asia Pacific
  - Asia Pacific Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
    - Branded
    - Generics
  - Asia Pacific Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - Asia Pacific Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - Asia Pacific Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - Japan
    - Japan Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Japan Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Japan Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Japan Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - China
    - China Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - China Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - China Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - China Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - India
    - India Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - India Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - India Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - India Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - South Korea
    - South Korea Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - South Korea Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - South Korea Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - South Korea Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Australia
    - Australia Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Australia Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Australia Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Australia Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Thailand
    - Thailand Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Thailand Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Thailand Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Thailand Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
- Latin America
  - Latin America Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
    - Branded
    - Generics
  - Latin America Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - Latin America Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - Latin America Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - Brazil
    - Brazil Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Brazil Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Brazil Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Brazil Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Mexico
    - Mexico Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Mexico Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Mexico Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Mexico Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Argentina
    - Argentina Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Argentina Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Argentina Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Argentina Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
- MEA
  - MEA Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
    - Branded
    - Generics
  - MEA Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
    - DNA Polymerase Inhibitors
    - Reverse Transcriptase Inhibitors
    - Protease Inhibitors
    - Neuraminidase Inhibitors
    - Others
  - MEA Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - MEA Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
    - HIV
    - Hepatitis
    - Herpes
    - Influenza
    - Others
  - South Africa
    - South Africa Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - South Africa Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - South Africa Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - South Africa Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Saudi Arabia
    - Saudi Arabia Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Saudi Arabia Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Saudi Arabia Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Saudi Arabia Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - UAE
    - UAE Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - UAE Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - UAE Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - UAE Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others
  - Kuwait
    - Kuwait Antiviral Drugs market, By Type, 2018 - 2030 (USD Million)
      - Branded
      - Generics
    - Kuwait Antiviral Drugs market, By Drug Class, 2018 - 2030 (USD Million)
      - DNA Polymerase Inhibitors
      - Reverse Transcriptase Inhibitors
      - Protease Inhibitors
      - Neuraminidase Inhibitors
      - Others
    - Kuwait Antiviral Drugs market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Kuwait Antiviral Drugs market, By Application, 2018 - 2030 (USD Million)
      - HIV
      - Hepatitis
      - Herpes
      - Influenza
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.